What is a trauma medical kit supply business in India?

A manufacturing and distribution business that produces standardized trauma, resuscitation, and emergency care kits certified to WHO/ISO 13485 standards. These kits are sold to governments, NGOs, hospitals, and humanitarian organizations across conflict and under-resourced regions. India's manufacturing cost advantage (40–50% cheaper than Western suppliers) makes it competitive in emerging markets.

How much does it cost to start this business in India?

₹45–65 lakh for MVP launch: Manufacturing setup (₹20L), ISO 13485 certification (₹8–10L), CDSCO licensing (₹5L), initial inventory (₹10–15L), and working capital. Scaling to ₹5 crore revenue requires ₹2–3 crore additional capex.

Is this business profitable in India?

Yes. Gross margins of 35–45% are typical for medical device kits. A 50,000-unit/year operation at ₹350–500 per kit generates ₹1.75–2.5 crore revenue with ₹60–100 lakh annual profit after compliance costs. NGO bulk contracts offer 25–30% price premiums for government/humanitarian buyers.

What regulations apply to this business in India?

CDSCO registration under Drugs and Cosmetics Act 1940 (Class B or C device), ISO 13485:2016 medical device quality management certification, GST 5% on medical devices, state manufacturing licenses, and export compliance for cross-border sales. Humanitarian organizations may qualify for duty waivers under UN protocols.

Trauma Medical Kit Supply Business India 2026 Guide

AI SummaryThe trauma medical kit supply business is a ₹8,500–12,000 crore opportunity across South Asia and Africa, driven by recurring mass-casualty events and chronic under-resourcing of emergency care in conflict zones. India's manufacturing cost advantage and regulatory framework (CDSCO, ISO 13485) position it as a natural supplier hub for NGOs, governments, and private hospitals across Pakistan, Afghanistan, Nigeria, and similar markets. With startup costs of ₹45–65 lakh and gross margins of 35–45%, the business achieves profitability within 18–24 months via bulk government contracts and humanitarian partnerships. Healthcare entrepreneurs, supply chain MBAs, and medical device professionals should pursue this opportunity immediately, as demand is accelerating with geopolitical instability.